Cambridge Investment Research Advisors, Inc. Medpace Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,182 shares of MEDP stock, worth $643,471. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,182
Previous 2,745
20.51%
Holding current value
$643,471
Previous $912,000
27.08%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MEDP
# of Institutions
624Shares Held
26MCall Options Held
46.4KPut Options Held
80.8K-
Black Rock Inc. New York, NY2.58MShares$760 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$747 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.19MShares$350 Million0.07% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT829KShares$245 Million1.43% of portfolio
-
State Street Corp Boston, MA783KShares$231 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $9.17B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...